| Literature DB >> 26743178 |
Chunsheng Liu1,2,3, Guanyong Su4,5, John P Giesy5,6,7, Robert J Letcher4, Guangyu Li1, Ira Agrawal3, Jing Li1, Liqin Yu1, Jianghua Wang1, Zhiyuan Gong3.
Abstract
Tris(1,3-dichloro-2-propyl) phosphate (TDCIPP) has been frequently detected in environmental media and has adverse health effect on wildlife and humans. It has been implicated to have hepatotoxicity, but its molecular mechanisms remain unclear. In the present study, adult male zebrafish were exposed to TDCIPP and global hepatic gene expression was examined by RNA-Seq and RT-qPCR in order to understand the molecular mechanisms of TDCIPP-induced hepatotoxicity. Our results indicated that TDCIPP exposure significantly up-regulated the expression of genes involved in endoplasmic reticulum stress and Toll-like receptor (TLR) pathway, implying an inflammatory response, which was supported by up-regulation of inflammation-related biomaker genes. Hepatic inflammation was further confirmed by histological observation of increase of infiltrated neutrophils and direct observation of liver recruitment of neutrophils labeled with Ds-Red fluorescent protein of Tg(lysC:DsRed) zebrafish upon TDCIPP exposure. To further characterize the hepatotoxicity of TDCIPP, the expression of hepatotoxicity biomarker genes, liver histopathology and morphology were examined. The exposure to TDCIPP significantly up-regulated the expression of several biomarker genes for hepatotoxicity (gck, gsr and nqo1) and caused hepatic vacuolization and apoptosis as well as increase of the liver size. Collectively, our results suggest that exposure to TDCIPP induces hepatic inflammation and leads to hepatotoxicity in zebrafish.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26743178 PMCID: PMC4705469 DOI: 10.1038/srep19045
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Enriched GO terms and pathways in response to TDCIPP exposure in zebrafish liver (P < 0.05).
| Terms | Count | Fold enrichment | Genes | ||
|---|---|---|---|---|---|
| Gene Ontology | |||||
| Biological Process | Innate immune response | 5 | 5.39E-3 | 6.92 | |
| Defense response | 6 | 1.32E-2 | 4.22 | ||
| Response to inorganic substance | 5 | 1.45E-2 | 5.23 | ||
| Transmembrane transport | 17 | 1.45E-2 | 1.92 | ||
| Metal ion transport | 12 | 1.94E-2 | 2.21 | ||
| Muscle organ development | 6 | 2.16E-2 | 3.73 | ||
| Cation transport | 14 | 2.97E-2 | 1.92 | ||
| Ion transport | 17 | 3.66E-2 | 1.72 | ||
| Response to xenobiotic | 3 | 4.05E-2 | 9.19 | ||
| Response to virus | 3 | 4.61E-2 | 8.58 | ||
| Cellular component | Endoplasmic reticulum | 14 | 3.54E-3 | 2.47 | |
| Molecular function | Nucleotidyltransferase activity | 6 | 3.17E-2 | 3.38 | |
| Oxidoreductase activity | 3 | 3.71E-2 | 9.65 | ||
| Dipeptidyl-peptidase activity | 2 | 4.64E-2 | 45.0 | ||
| KEGG Pathways | |||||
| Steroid hormone biosynthesis | 4 | 1.59E-2 | 7.32 | ||
| Toll-like receptor signaling pathway | 6 | 2.91E-2 | 3.40 | ||
Time-dependent expression profiles of genes included in different functional categories in zebrafish liver after exposure to the solvent alone (0.01% DMSO) or 1 mg/L TDCIPP.
| Functional categories | Genes | 1 day | 2 days | 4 days |
|---|---|---|---|---|
| Innate immune | 0.85 ± 0.42 | 1.93 ± 0.20> | 18.75 ± 6.53 | |
| response | 0.83 ± 0.23 | 3.10 ± 0.52 | 15.26 ± 5.03 | |
| (GO)/Toll-like | 0.74 ± 0.27 | 2.62 ± 0.34 | 23.54 ± 10.49 | |
| receptor | 0.65 ± 0.14 | 3.67 ± 1.00 | 28.73 ± 11.24 | |
| signaling | 0.83 ± 0.23 | 3.59 ± 1.04 | 21.93 ± 9.31 | |
| pathway (KEGG) | 0.73 ± 0.22 | 2.62 ± 1.04 | 18.14 ± 4.85 | |
| 1.17 ± 0.38 | 5.00 ± 1.83 | 3.92 ± 1.17 | ||
| 1.10 ± 0.30 | 3.33 ± 1.01 | 2.19 ± 0.42 | ||
| ER stress | 0.96 ± 0.22 | 1.90 ± 0.24 | 10.62 ± 2.88 | |
| 1.25 ± 0.27 | 3.17 ± 0.49 | 9.91 ± 3.09 | ||
| Inflammation | 0.95 ± 0.27 | 4.50 ± 1.50 | 3.40 ± 1.30 | |
| response | 0.91 ± 0.28 | 3.75 ± 0.86 | 0.98 ± 0.47 | |
| 0.81 ± 0.42 | 2.48 ± 0.76 | 12.79 ± 5.20 | ||
| 0.79 ± 0.30 | 2.94 ± 0.82 | 3.56 ± 0.52 | ||
| 1.22 ± 0.38 | 1.44 ± 0.43 | 5.95 ± 1.23 | ||
| 0.73 ± 0.33 | 1.04 ± 0.29 | 23.24 ± 9.15 | ||
| 1.01 ± 0.15 | 1.40 ± 0.18 | 4.16 ± 1.02 | ||
| 0.85 ± 0.38 | 1.37 ± 0.39 | 5.75 ± 2.46 | ||
| 0.70 ± 0.30 | 1.19 ± 0.76 | 23.30 ± 8.81 |
Values represent mean ± SEM (n = 9). Significant differences from the control are indicated by *P < 0.05.
Dose-dependent expression profiles of genes included in different functional categories in zebrafish liver after exposure to the solvent alone (0.01% DMSO) or different concentrations of TDCIPP for 4 days.
| Functional categories | Genes | 0.1 mg/L | 0.3 mg/L | 1 mg/L |
|---|---|---|---|---|
| Innate immune | 0.97 ± 0.28 | 0.76 ± 0.09 | 18.75 ± 6.53 | |
| response | 1.11 ± 0.34 | 0.70 ± 0.12 | 15.26 ± 5.03 | |
| (GO)/Toll-like | 1.18 ± 0.38 | 0.83 ± 0.21 | 23.54 ± 10.49 | |
| receptor | 0.91 ± 0.30 | 0.78 ± 0.07 | 28.73 ± 11.24 | |
| signaling | 0.80 ± 0.22 | 0.63 ± 0.16 | 21.93 ± 9.31 | |
| pathway (KEGG) | 1.24 ± 0.49 | 0.74 ± 0.20 | 18.14 ± 4.85 | |
| 6.00 ± 2.00 | 4.73 ± 1.63 | 3.92 ± 1.17 | ||
| 1.34 ± 0.54 | 2.47 ± 0.67 | 2.19 ± 0.42 | ||
| ER stress | 1.80 ± 0.60 | 2.08 ± 0.36 | 10.62 ± 2.88 | |
| 1.21 ± 0.36 | 0.80 ± 0.13 | 9.91 ± 3.09 | ||
| Inflammation | 1.99 ± 0.90 | 2.10 ± 0.92 | 3.40 ± 1.30 | |
| response | 2.76 ± 1.09 | 1.34 ± 0.40 | 0.98 ± 0.47 | |
| 3.77 ± 2.27 | 2.00 ± 0.90 | 12.79 ± 5.20 | ||
| 2.11 ± 1.91 | 1.74 ± 0.91 | 3.56 ± 0.52 | ||
| 1.19 ± 0.39 | 0.74 ± 0.24 | 5.95 ± 1.23 | ||
| 1.65 ± 0.91 | 2.35 ± 0.55 | 23.24 ± 9.15 | ||
| 0.64 ± 0.10 | 0.66 ± 0.21 | 4.16 ± 1.02 | ||
| 2.35 ± 0.59 | 3.15 ± 0.70 | 5.75 ± 2.46 | ||
| 1.13 ± 0.75 | 2.21 ± 1.53 | 23.30 ± 8.81 |
Values represent mean ± SEM (n = 9). Significant differences from the control are indicated by *P < 0.05.
Figure 1Effects on expressions of four proteins selected (Grp78, Chop, Fos and Il6) in response to 1 mg/L TDCIPP.
(A) Western blots of four proteins selected from control and TDCIPP groups; (B) Quantification of the relative expressions of four proteins selected in control and treatment groups. C: control group; T: treatment group. Values represent mean ± SEM (n = 3). Asterisks indicate significant differences from matched control samples (P < 0.05).
Figure 2Dose- (A) and time-dependent (B) effects on the expression of selected hepatotoxicity biomarker genes (gclc, gsr and nqo1) in response to TDCIPP.(C): control group; T: treatment group. Values represent mean ± SEM (n = 9). Asterisks indicate significant differences from matched control samples (P < 0.05).
Figure 3Changes of liver histology of male zebrafish after exposure to 1 mg/L TDCIPP for 4 days.
Liver sections were stained by hematoxylin and eosin. (A) representative liver section from the DMSO vehicle control group. (B,C) Two representative liver sections from two individual fish of the same TDCIPP group with a moderate effect (B) and a severe effect (C). The left images have a magnification of 200X and the right images have a magnification of 400X. Several features are exampled by arrows of different colors: neutrophils (black); apoptosis (red); hepatic vacuolization (green).
Figure 4Dose- (A) and time-dependent (B) increase of neutrophils in the livers of Tg(lysC:dDsRed) zebrafish larvae in response to TDCIPP exposure.Images were captured with a digital camera attached to a Carl Zeiss LSM 510 Meta fluorescent microscope. (C) Representative images from control group and 4-day TDCIPP (1 mg/L) exposure group. The livers are outlined with white lines. Values represent mean ± SEM. Significant difference between the two groups were observed: P < 0.05.
Figure 5Dose- (A) and time-dependent (B) increase of liver size in Tg(fabp10a:DsRed) zebrafish larvae after exposure to TDCIPP.Images were captured with a digital camera attached to a Carl Zeiss LSM 510 Meta fluorescent microscope. Liver sizes were measured based on the 2D image using the ImageJ software. (C) Representative images from control group and 4-day TDCIPP (1 mg/L) exposure group Values represent mean ± SEM. Significant difference between the two groups were observed: P < 0.05.